跳至主要内容
临床试验/NCT04832659
NCT04832659进行中(未招募)不适用

Assessment of Biomarkers in Children to Help Parents Quit Tobacco

Massachusetts General Hospital2 个研究点 分布在 1 个国家目标入组 865 人开始时间: 2023年1月20日最近更新:
适应症
干预措施

试验速览

阶段
不适用
状态
进行中(未招募)
入组人数
865
试验地点
2
主要终点
Parental quit rate

研究概览

简要总结

This randomized controlled trial will test whether adding biomarker measurement and informed outreach for tobacco smoke exposure as part of routine practice increases identification and improves treatment, effectiveness, and sustainability of a parental tobacco control intervention that will be integrated into pediatric practice.

详细描述

This trial will examine the effectiveness of systematic cotinine testing of children 12 years old or younger using blood already collected at any visit to a practice that sees pediatric patients where there is a clinically indicated blood draw. We hypothesize that providing cotinine biomarker results to pediatricians, personalized cotinine feedback to parents about their child's toxin exposure, and offering support to all household tobacco users to quit tobacco use (Biomarker Informed Outreach (BIO)) when added to the Clinical Effort Against Secondhand Smoke Exposure (CEASE) intervention will increase delivery of tobacco cessation assistance, increase household cessation, reduce tobacco smoke exposure in children, and be cost-effective. This is a 2-arm randomized controlled trial with family-level randomization to either CEASE+BIO or CEASE arms at the time of the child's baseline visit. To compare the effectiveness of CEASE+BIO vs. CEASE, we will follow-up with enrolled parents 12 months later to assess parental quit rate and children's tobacco smoke exposure.

研究设计

研究类型
Interventional
分配方式
Randomized
干预模型
Parallel
主要目的
Treatment
盲法
None

入排标准

年龄范围
18 Years 至 —(Adult, Older Adult)
性别
All
接受健康志愿者

入选标准

  • Child 12 years old or younger presenting for a visit.
  • Child scheduled for or has had a clinically indicated blood draw at that visit
  • Parent/legal guardian of the child.
  • Parent/legal guardian is a current smoker (past 7 days).

排除标准

  • Parent/legal guardian is non-English speaking.
  • Parent/legal guardian is less than 18 years of age.

研究组 & 干预措施

CEASE

Active Comparator

Those assigned to the Active Comparator arm will receive the CEASE intervention.

干预措施: CEASE (Behavioral)

CEASE + BIO

Experimental

Those assigned to the Experimental CEASE + BIO arm will receive the CEASE intervention plus Biomarker Informed Outreach (BIO).

干预措施: CEASE (Behavioral)

CEASE + BIO

Experimental

Those assigned to the Experimental CEASE + BIO arm will receive the CEASE intervention plus Biomarker Informed Outreach (BIO).

干预措施: CEASE + BIO (Behavioral)

结局指标

主要结局

Parental quit rate

时间窗: 12 months

Parental 7-day point-prevalence tobacco abstinence at 12-month follow-up, biochemically confirmed (corrected for NRT use)

Parental quit rate

时间窗: 12 months

Parental 7-day point-prevalence tobacco abstinence at 12-month follow-up, biochemically confirmed (corrected for NRT use)

次要结局

  • Self-report parental 7-day point prevalence tobacco abstinence(12 months)

研究者

申办方类型
Other
责任方
Principal Investigator
主要研究者

Jonathan P. Winickoff, MD, MPH

Professor

Massachusetts General Hospital

研究点 (2)

Loading locations...

相似试验